RxDoctor Payments Data

Christopher Stephany, PA

Physician Assistant · Springville, NYNPI 1942759287

Payments from drug & device makers

$773in general payments, 2019–2025

Across 43 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$138
  • Novo Nordisk$85
  • Pfizer$80
  • AbbVie$66
  • Exact Sciences$55
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$54
  • plus $296 from 10 others

What the payments were for

  • Food & beverage$773100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$773 in reported general payments places this provider in the 70th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$13,617
Medicare patients
108
Services billed
289

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban29$34,706
JardianceEmpagliflozin37$31,972
OzempicSemaglutide20$17,831
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$13,437
Repatha SyringeEvolocumab17$9,094
Breo ElliptaFluticasone/Vilanterol12$4,576
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$3,093
Albuterol Sulfate HfaAlbuterol Sulfate78$1,893
Levothyroxine Sodium107$1,713
Omeprazole109$1,713
Atorvastatin Calcium128$1,694
Rosuvastatin Calcium76$1,170
Metoprolol Succinate56$987
Lisinopril114$952
Metformin Hcl104$944

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$80$34,70629 claims
Boehringer IngelheimJardiance$28$31,97237 claims
GSKTrelegy Ellipta, Breo Ellipta$15$18,01425 claims
Novo NordiskOzempic$85$17,83120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Springville

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →